Zoledronic acid
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 165800-06-6
Synonym(S): Zoledronic acid monohydrate, P,P′-[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic acid monohydrate, Zoledronate monohydrate, [1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid) monohydrate
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 150 MG | 1724827-150-MG | In Stock | ₹ 40,756.13 |
1724827 - 150 MG
In Stock
Quantity
1
Base Price: ₹ 40,756.13
GST (18%): ₹ 7,336.103
Total Price: ₹ 48,092.233
grade
pharmaceutical primary standard
API family
zoledronic acid
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
O.OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O
InChI
1S/C5H10N2O7P2.H2O/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7;/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14);1H2
InChI key
FUXFIVRTGHOMSO-UHFFFAOYSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Sigma Aldrich Fine Chemicals Biosciences Zoledronic acid monohydrate >=98% (HPLC) | 165800-06-6 | MFCD08448695 | 10MG | -- | ₹ 12,538.32 | ||
Sigma Aldrich Fine Chemicals Biosciences Zoledronic acid monohydrate >=98% (HPLC) | 165800-06-6 | MFCD08448695 | 50MG | -- | ₹ 49,555.20 | ||
Sigma Aldrich Fine Chemicals Biosciences Zoledronic acid United States Pharmacopeia (USP) Reference Standard | 165800-06-6 | MFCD08448695 | 150MG | -- | ₹ 47,632.80 | ||
Enzo Life Sciences Zoledronic acid (1g). CAS: 165800-06-6 | -- | ₹ 78,149.12 | ||
Enzo Life Sciences Zoledronic acid (100mg). CAS: 165800-06-6 | -- | ₹ 35,720.15 | ||
Zoledronic Acid | -- | ₹ 27,279.00 | ||
Zoledronic acid monohydrate | -- | ₹ 14,072.50 | ||
Phosphonic acid, P,P'-[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-, hydrate (1:1) | -- | ₹ 890.00 - ₹ 24,119.00 | ||
Zoledronic acid monohydrate | -- | ₹ 6,497.00 - ₹ 22,606.00 | ||
165800-06-6 | Zoledronic acid hydrate | -- | ₹ 890.00 - ₹ 63,813.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Zoledronic acid USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
- Biochem/physiol Actions: Zoledronic acid (zoledronate) is a bisphosphonate bone resorption inhibitor, an inhibitor of farnesyl diphosphate (FPP) synthase which results in downstream inhibition of osteoclast activity and reduced bone resorption and turnover. It has been used to treat postmenopausal osteoporosis, Paget′s disease, hypercalcemia, and along with cancer chemotherapy to treat bone damage caused by cancer that has spread to the bones.
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable